accur
assess
neutral
antibodi
activ
import
either
patient
infect
sever
acut
respiratori
syndrom
sar
anim
volunt
immun
experiment
vaccin
sar
associ
coronaviru
scv
howev
current
assay
base
cytopath
effect
cpe
frequent
cite
literatur
sever
limit
cpe
assay
reli
visual
observ
damag
scv
infect
target
cell
microscop
subject
observ
variat
difficult
gener
quantit
determin
neutral
activ
base
level
cpe
current
studi
establish
util
two
addit
assay
measur
neutral
activ
scv
plaqu
reduct
pr
neutral
red
stain
nr
assay
pr
assay
describ
studi
modifi
tradit
viral
plaqu
reduct
assay
use
improv
crystal
stain
method
achiev
better
plagu
format
scv
infect
vero
cell
nr
neutral
assay
adopt
similar
system
use
detect
neutral
antibodi
respons
human
immunodefici
viru
type
assay
protect
effect
neutral
antibodi
determin
cell
viabil
measur
uptak
neutral
red
dye
neutral
antibodi
titer
easili
determin
either
two
new
assay
report
describ
util
two
new
neutral
assay
measur
neutral
activ
scv
infect
rabbit
sera
immun
variou
form
spike
protein
scv
sever
acut
respiratori
syndrom
sar
associ
coronaviru
scv
new
member
coronavirida
caus
highli
virul
emerg
infecti
diseas
human
popul
spread
mani
part
world
ksiazek
et
al
kuiken
et
al
peiri
et
al
poutanen
et
al
scv
transmit
rapidli
person
person
approxim
case
fatal
rate
although
first
epidem
success
contain
new
case
report
fall
enserink
normil
b
sar
still
remain
threat
due
highli
transmitt
natur
human
popul
mysteri
origin
scv
arita
et
al
chan
et
al
inouy
ratzan
sampathkumar
et
al
tong
liang
current
proven
antivir
drug
effect
viral
infect
holm
kuiken
et
al
normil
develop
effect
vaccin
scv
costeffect
approach
achiev
protect
larg
popul
suscept
scv
infect
report
high
titer
protect
antibodi
present
convalesc
sera
scv
infect
patient
passiv
transfer
sera
could
improv
clinic
outcom
sar
li
et
al
pearson
impli
vaccin
elicit
robust
humor
immun
protect
scv
infect
elimin
reduc
cellfre
viral
infect
chantler
davi
burton
maruyama
et
al
roehrig
et
al
burton
et
al
evalu
neutral
antibodi
activ
serum
sampl
either
scv
infect
host
immun
candid
scv
vaccin
critic
establish
highli
reproduc
quantit
vitro
viru
neutral
assay
sinc
discoveri
sar
neutral
antibodi
scv
infect
mainli
detect
simpl
microneutr
assay
base
cytopath
effect
cpe
scv
target
cell
li
et
al
buchholz
et
al
sui
et
al
zeng
et
al
method
reli
direct
observ
damag
target
cell
scv
infect
microscop
howev
result
influenc
subject
interpret
research
easi
quantit
determin
neutral
activ
base
degre
cytopath
effect
complet
protect
cell
easili
distinguish
damag
cell
partial
protect
cell
popul
hard
evalu
therefor
difficult
come
titrat
curv
measur
strength
neutral
antibodi
serial
dilut
test
antibodi
tradit
variou
neutral
assay
develop
mani
differ
virus
plaqu
reduct
assay
wide
use
evalu
neutral
antibodi
respons
virus
form
plaqu
infect
cell
rubella
rhim
schell
sato
et
al
flaviviru
russel
nisalak
ibrahim
et
al
vaccinia
kitamura
et
al
newman
et
al
measl
virus
orenstein
et
al
vazquezrosal
et
al
howev
unpublish
data
includ
observ
plaqu
form
scv
infect
target
cell
vero
poor
could
visual
clearli
unless
microscop
use
current
studi
improv
plaqu
format
scv
infect
monolay
target
cell
plaqu
could
easili
count
scv
neutral
antibodi
analysi
neutral
assay
base
target
cell
viabil
also
wide
use
studi
neutral
activ
neutral
red
dye
use
stain
live
healthi
cell
protect
infect
montefiori
et
al
studi
cell
use
target
cell
montefiori
et
al
montefiori
et
al
current
report
demonstr
neutral
red
method
use
stain
vero
cell
main
target
cell
line
scv
infect
new
zealand
white
rabbit
sera
specif
differ
segment
scv
spike
protein
produc
dna
immun
recent
report
tabl
wang
et
al
rabbit
immun
four
biweekli
immun
gene
gun
immun
sera
test
studi
collect
two
week
immun
sera
store
heatinactiv
minut
use
african
green
monkey
kidney
vero
cell
american
type
cultur
collect
manassa
va
use
propag
scv
neutral
assay
cell
cultur
dulbecco
modifi
eagl
medium
dmem
supplement
unitsml
penicillin
g
mgml
streptomycin
mm
lglutamin
heatinactiv
fetal
bovin
serum
fb
cell
cultur
maintain
co
urbani
strain
scv
use
studi
obtain
us
center
diseas
control
prevent
cdc
atlanta
ga
procedur
handl
scv
infect
cell
cultur
held
special
biosafeti
level
laboratori
protocol
approv
institut
biosafeti
committe
ibc
produc
scv
stock
viru
propag
vero
cell
multipl
infect
moi
cultur
medium
collect
day
filter
micron
filter
remov
cell
debri
titer
viru
stock
determin
vero
cell
monolay
seed
microtit
plate
corn
ny
cellswel
viru
tissu
cultur
infecti
dose
tcid
determin
endpoint
titrat
assay
describ
previous
li
et
al
cpe
base
microneutr
assay
conduct
microtit
plate
describ
li
et
al
three
fold
dilut
heatinactiv
rabbit
sera
test
triplic
well
presenc
antibodi
neutral
infect
scv
monolay
vero
cell
tcid
viru
alwel
incub
al
rabbit
serum
tissu
cultur
medium
hour
incub
vero
cell
al
ad
well
moi
result
neutral
determin
appear
cpe
observ
microscop
day
infect
neutral
antibodi
titer
defin
reciproc
highest
serum
dilut
cpe
breakthrough
triplic
test
well
observ
scv
plaqu
form
unit
pfu
viru
stock
determin
plaqu
assay
tissu
cultur
plate
vero
cell
cell
per
well
seed
onto
tissu
cultur
plate
day
infect
next
day
pfu
tcid
equival
scv
al
first
incub
without
serial
dilut
antibodi
total
volum
al
ubottom
tissu
cultur
plate
hour
mixtur
ad
vero
cell
seed
plate
remov
cultur
medium
incub
hour
plate
wash
dmem
monolay
cell
overlaid
ml
valu
geometr
mean
f
standard
deviat
independ
assay
dmem
medium
contain
wv
methylcellulos
cp
sigma
mo
day
incub
vero
monolay
wash
pb
fix
al
prechil
formaldehyd
min
room
temperatur
follow
aspir
remov
formaldehyd
solut
twice
pb
wash
monolay
stain
al
crystal
violet
min
room
temperatur
plate
wash
twice
water
plate
air
dri
plaqu
count
neutral
calcul
percentag
number
plaqu
reduc
particular
test
serum
compar
mean
plaqu
count
three
viru
control
well
without
sera
assay
neutral
antibodi
titer
determin
highest
serum
dilut
achiev
plaqu
reduct
nr
neutral
assay
perform
flat
bottom
plate
setup
similar
cpe
base
neutral
assay
briefli
incub
tcid
viru
rabbit
serum
total
al
dmem
medium
per
well
hour
vero
cell
cell
al
ad
well
moi
day
infect
cell
form
cpe
viral
control
well
without
sera
cultur
medium
remov
test
well
al
neutral
red
sigma
dmem
medium
ad
well
incub
hour
neutral
red
medium
remov
plate
wash
twice
phosphat
buffer
salin
pb
ph
al
acid
alcohol
acet
acid
ethanol
ad
well
incub
minut
room
temperatur
absorb
neutral
red
stain
plate
read
nm
cpe
base
neutral
assay
first
frequent
use
neutral
assay
sar
research
wang
et
al
howev
way
determin
neutral
antibodi
titer
inconsist
poorli
describ
literatur
assay
reli
entir
observ
cell
morpholog
determin
effect
neutral
antibodi
shown
fig
infect
scv
day
vero
cell
microtit
plate
start
form
visibl
cpe
includ
dissoci
cell
pattern
degre
cpe
score
less
sever
bq
fig
right
well
sever
bq
fig
center
well
compar
protect
monolay
cell
presenc
posit
anti
rabbit
sera
fig
left
well
observ
microscop
howev
degre
morpholog
chang
hard
quantifi
may
subject
observerst
variat
limit
becom
even
problemat
titer
neutral
antibodi
need
determin
fig
depict
one
sampl
assay
hyperimmun
posit
anti
rabbit
serum
serial
dilut
dilut
cpe
first
observ
sera
dilut
reach
fig
indic
howev
cpe
appear
three
test
well
time
level
cpe
well
also
vari
data
shown
order
give
consist
score
neutral
antibodi
respons
titer
posit
sera
determin
either
complic
score
system
base
mani
well
show
cpe
given
sera
dilut
simpli
base
last
sera
dilut
none
triplic
well
visibl
cpe
exampl
fig
use
latter
criteria
panel
rabbit
sera
elicit
dna
vaccin
express
differ
form
scv
antigen
analyz
tabl
full
length
antigen
ntermin
subunit
antigen
induc
excel
neutral
antibodi
scv
ctermin
subunit
also
elicit
posit
albeit
low
level
neutral
activ
recent
report
wang
et
al
subunit
protein
divid
two
separ
domain
clear
neutral
epitop
locat
region
bind
domain
scv
receptor
li
et
al
region
show
neutral
activ
tabl
cpe
assay
use
assaytoassay
variat
signific
shown
high
standard
deviat
tabl
like
due
variat
observ
chang
cpe
stringent
criteria
absent
cpe
test
well
appli
problem
becom
sever
differ
research
involv
score
cpe
cpe
assay
also
less
effect
provid
quantit
measur
antibodi
strength
concentr
sera
inhibit
infect
note
among
research
work
scv
vero
cell
form
tini
plaqu
convent
plaqu
assay
techniqu
use
fig
usual
requir
high
concentr
scv
result
plaqu
hard
count
even
microscop
improv
plaqu
format
discov
overlay
methylcellulos
proper
concentr
molecular
weight
cp
critic
improv
method
clear
plaqu
form
well
infect
scv
uninfect
cell
control
well
remain
free
plaqu
fig
perform
neutral
studi
tissu
cultur
plate
modifi
plaqu
reduct
assay
valid
plaqu
reduct
base
neutral
assay
posit
anti
rabbit
serum
neg
control
rabbit
serum
use
seri
rabbit
sera
dilut
ad
number
plaqu
well
count
light
sourc
fig
number
plaqu
well
increas
along
dilut
anti
rabbit
serum
number
plaqu
neg
sera
control
well
remain
unchang
percentag
plaqu
reduct
presenc
posit
antibodi
calcul
use
formula
plaqu
reduct
plaqu
count
test
well
plaqu
count
cell
control
plaqu
count
viral
control
plaqu
count
cell
control
neutral
antibodi
titer
plaqu
reduct
assay
report
reciproc
serum
dilut
plagu
reduct
achiev
compar
viral
control
well
use
assay
neutral
antibodi
activ
set
posit
anti
rabbit
sera
analyz
tabl
plaqu
reduct
assay
demonstr
similar
pattern
rel
level
neutral
antibodi
activ
cpe
assay
neutral
titer
determin
plaqu
reduct
assay
gener
lower
achiev
cpe
assay
suggest
plaqu
reduct
assay
may
less
sensit
cpe
assay
determin
neutral
activ
scv
infect
cell
viabil
upon
viral
infect
also
measur
neutral
red
stain
previous
use
techniqu
evalu
cell
viabil
infect
target
cell
neutral
red
dye
taken
healthi
cell
stain
wash
pb
neutral
red
stain
method
appli
vero
cell
target
cell
scv
infect
despit
adher
epitheli
cell
form
monolay
attach
tissu
cultur
plate
stain
wash
healthi
vero
cell
hold
neutral
red
dye
damag
cell
infect
scv
proport
healthi
cell
could
determin
read
absorb
neutral
red
well
note
viruscel
ratio
import
type
neutral
assay
optim
ratio
infect
cell
scv
virus
plate
practic
seri
dilut
rabbit
sera
incub
viru
triplic
well
viral
control
sera
octav
well
well
cell
control
without
viru
sera
signific
number
vero
cell
scv
c
repres
plaqu
reduct
base
neutral
assay
methycellulos
method
serial
dilut
anti
rabbit
serum
neg
control
rabbit
serum
ad
vero
cell
incub
scv
see
tabl
descript
two
rabbit
sera
viral
control
well
form
cpe
compar
cell
control
well
cell
stain
neutral
red
fraction
viabl
cell
presenc
neutral
antibodi
quantifi
stain
cell
intens
stain
directli
proport
number
viabl
cell
percent
neutral
determin
formula
neutral
antibodi
test
well
viral
control
well
cell
control
well
viral
control
well
neutral
antibodi
titer
neutral
red
assay
report
ic
reciproc
serum
dilut
vero
cell
protect
viru
induc
kill
one
major
advantag
neutral
red
stain
base
assay
level
surviv
cell
measur
directli
read
plot
dilut
neutral
rabbit
sera
result
sampl
experi
shown
fig
ic
easili
determin
method
neutral
antibodi
titer
panel
test
anti
rabbit
sera
determin
neutral
red
stain
compar
measur
cpe
plaqu
reduct
assay
tabl
appear
neutral
red
stain
sensit
method
detect
posit
neutral
activ
overal
pattern
level
neutral
antibodi
activ
among
posit
rabbit
sera
similar
independ
type
assay
use
rabbit
serum
specif
fragment
alway
highest
neutral
activ
rabbit
serum
specif
subunit
least
posit
neutral
activ
tabl
two
region
spike
protein
scv
shown
two
neutral
domain
wang
et
al
rabbit
sera
elicit
larger
antigen
either
full
length
protein
entir
subunit
show
variat
neutral
antibodi
activ
differ
neutral
assay
use
possibl
antibodi
target
nonneutr
epitop
sera
may
interfer
antibodi
target
neutral
epitop
preble
sera
sera
rabbit
immun
either
vector
control
fragment
dna
vaccin
show
posit
neutral
activ
three
assay
indic
overal
high
specif
test
result
tabl
calcul
base
four
independ
experi
three
assay
fig
experimenttoexperi
variat
assay
reproduc
plagu
reduct
neutral
red
stain
assay
much
better
cpe
assay
serum
dilut
neutral
fig
scv
neutral
titer
determin
neutral
red
stain
assay
percent
viabl
cell
determin
neutral
red
stain
plot
dilut
test
rabbit
sera
curv
repres
result
one
rabbit
serum
posit
anti
rabbit
sera
neg
control
rabbit
serum
level
neutral
activ
shown
percent
inhibit
scv
infect
vero
cell
compar
viral
control
well
exampl
neutral
titer
determin
use
inhibit
cutoff
line
shown
figur
report
describ
util
two
assay
adapt
measur
neutral
antibodi
respons
scv
vero
cell
addit
previous
report
cpe
assay
first
success
improv
tradit
plaqu
reduct
assay
form
better
scv
plaqu
infect
vero
cell
discov
molecular
weight
methylcellulos
import
plaqu
format
methylcellulos
cp
mainten
medium
use
overlay
medium
produc
easili
visibl
plaqu
test
plate
howev
methylcellulos
compound
lower
higher
molecular
weight
could
achiev
result
find
reestablish
util
plaqu
assay
sar
research
assay
use
pathogenesi
studi
monitor
viral
titer
without
use
complic
molecular
biochem
analys
quantifi
amount
scv
procedur
lower
risk
handl
hazard
scv
high
potenti
human
transmiss
shown
previou
laboratori
accid
normil
c
watt
improv
plaqu
format
techniqu
also
appli
studi
virus
may
also
difficulti
produc
plaqu
visibl
size
also
appli
neutral
red
stain
method
scv
infect
vero
cell
previous
techniqu
use
neutral
assay
infect
cell
transfer
microtit
plate
precoat
polyllysin
captur
suspend
cell
neutral
red
stain
montefiori
et
al
captur
healthi
cell
could
uptak
hold
neutral
red
dye
without
wash
pb
infect
cell
form
synthicia
cpe
cell
viabil
could
easili
determin
measur
absorb
neutral
red
dye
releas
cell
extract
acid
alcohol
although
vero
cell
adher
epitheli
cell
attach
bottom
tissu
cultur
plate
demonstr
direct
stain
vero
cell
infect
scv
plate
work
well
order
achiev
best
read
special
attent
place
number
cell
seed
plate
viruscel
ratio
concentr
neutral
red
mani
cell
seed
would
gener
high
background
stain
due
overgrown
cell
hand
cell
number
low
differ
read
cell
control
read
viral
control
would
also
small
denomin
calcul
percentag
neutral
prefer
rang
differ
viral
infect
well
cell
control
well
similar
sever
report
initi
use
cpe
assay
evalu
neutral
antibodi
respons
rais
scv
dna
vaccin
wang
et
al
cpe
assay
simpl
requir
special
reagent
devic
regular
light
microscop
howev
score
scv
induc
cpe
microscop
could
highli
subject
sometim
result
report
differ
observ
may
vari
sinc
cpe
score
mainli
base
morpholog
cell
condit
evolv
process
difficult
standard
score
base
degre
cpe
previou
studi
stringent
standard
use
cpe
base
neutral
assay
score
posit
cpelik
morpholog
cell
observ
although
cpe
assay
use
would
ideal
develop
quantit
object
assay
studi
demonstr
improv
plaqu
reduct
assay
establish
measur
neutral
antibodi
activ
scv
infect
previous
plaqu
assay
use
success
wide
rang
viral
infect
neutral
studi
includ
vaccinia
kitamura
et
al
newman
et
al
measl
orenstein
et
al
vazquezrosal
et
al
rabi
yoshino
morishima
wiktor
clark
cardoso
pilz
howev
neutral
antibodi
titer
observ
plaqu
reduct
assay
studi
lower
determin
cpe
assay
neutral
red
stain
assay
one
import
factor
differ
may
due
differ
amount
viru
use
assay
moi
plaqu
reduct
assay
neutral
red
stain
cpe
assay
differ
neutral
titer
also
observ
neutral
antibodi
vaccinia
plaqu
reduct
assay
biomark
assay
earl
et
al
therefor
plaqu
reduct
assay
may
use
differenti
high
titer
low
titer
antiscv
antibodi
uniqu
advantag
plaqu
reduct
assay
plate
store
longer
time
assay
hand
neutral
red
stain
base
assay
gave
higher
neutral
antibodi
titer
cpe
plaqu
reduct
assay
set
posit
rabbit
sera
besid
fact
less
viru
use
neutral
red
stain
assay
plaqu
reduct
assay
measur
rang
optim
neutral
red
stain
assay
provid
suffici
read
rang
fulli
demonstr
neutral
potenti
posit
rabbit
sera
main
advantag
neutral
red
stain
method
quantit
measur
neutral
activ
accomplish
plate
reader
improv
effici
reproduc
although
neutral
antibodi
titer
differ
depend
type
assay
use
studi
gener
pattern
neutral
activ
among
set
test
rabbit
sera
consist
none
neg
control
sera
show
detect
neutral
activ
indic
high
specif
assay
therefor
two
addit
neutral
assay
scv
serv
use
tool
sar
research
includ
sever
clinic
trial
recent
start
human
volunt
test
immunogen
candid
sar
vaccin
